Overview of Dr. Smithy
Dr. James Smithy is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Yale School of Medicine and has been in practice 0 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 89 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
160 E 53rd St
New York, NY 10022
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
- Brigham and Women's HospitalChief Residency, Internal Medicine, 2021 - 2022
- Brigham and Women's HospitalResidency, Internal Medicine, 2017 - 2020
- Yale School of MedicineClass of 2017
Certifications & Licensure
- FL State Medical License 2023 - Present
- MA State Medical License 2017 - 2026
- CT State Medical License 2023 - 2025
- NJ State Medical License 2023 - 2025
- NY State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 165 citationsA Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1Patricia Gaule, James W. Smithy, Maria I. Toki, Jamaal Rehman, Farah Patell-Socha
JAMA Oncology. 2017-02-01 - 98 citationsIdentification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.Lauren A. Eberly, Aaron Richterman, Anne G. Beckett, Bram Wispelwey, Regan H. Marsh
Circulation. Heart Failure. 2019-10-29 - 108 citationsHigh-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling.Maria I. Toki, Chris Merritt, Pok Fai Wong, James W. Smithy, Harriet M. Kluger
Clinical Cancer Research. 2019-09-15
Professional Memberships
- American Society of Clinical OncologyMember
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: